Smithsonian Magazine on MSN
A New Trial Put Immune System-Boosting Therapies to the Test to Fight HIV, Raising Hopes for Keeping the Virus at Bay
In the small study, seven out of ten participants maintained low levels of HIV for several months after receiving the ...
UCSF researchers have found a treatment for HIV that shows potential as a long-term solution for the chronic disease that, up ...
People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...
HIV treatment has entered a revolutionary new era, one where a single yearly injection can keep the virus undetectable, and ...
A small UCSF study has found that a combination of vaccines, antibodies, and immune-activating drugs helped some HIV-positive ...
HIV treatment has significantly evolved over the past 30 years, transforming HIV from a fatal disease to a manageable chronic ...
By Kisean Joseph [email protected] Ground-breaking advancements in HIV treatment and prevention could ...
Multiple pre-exposure (PrEP) and postexposure (PEP) treatments are now available to prevent HIV infection. An updated ...
A new study conducted across three African countries has found that an injectable HIV treatment--Cabotegravir/Rilpivirine (CAB LA + RPV LA), administered every two months--is safe, well tolerated, and ...
For breastfeeding women who have HIV, consistently taking antiretroviral therapy (ART) is essential for their own health and ...
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback